Oncology Drug Development in Practice 2015

This 3-day educational program, offered by Congress by design and INC Research, teaches knowledge and skills needed by professionals in oncology drug development working in the corporate or the academic setting. It is the continuation of a highly successful program offered annually since 2004.

Education offered

Oncology drug development is different from drug development in other therapeutic areas. The specific features of the preclinical and clinical development of new therapeutic agents for the treatment of cancer will be addressed during this course. The course will cover the complete development process, from preclinical development, through early-phase and late-phase clinical development, to post-registration clinical studies. It will also address essentials of tumor biology, medical oncology, hemato-oncology, tumor immunology and immunotherapy as well as biostatical and regulatory issues in the development of cancer therapeutics.